INTRODUCTION
Hepatic steatosis is a hallmark of nonalcoholic fatty liver disease (NAFLD); however, it is a frequent histological finding in other metabolic liver diseases including chronic hepatitis C (1, 2).
NAFLD encompasses a wide range of liver injury, from simple steatosis to nonalcoholic steatohepatitis (NASH) or even cirrhosis or fibrosis (3, 4) . The pathogenesis of NASH begins with increased synthesis and/or decreased oxidation of triglycerides (TGs) in the hepatocyte, thereby leading to increased fat accumulation. Because steatosis may render the liver more vulnerable to inflammation and fibrosis (5) , there is increasing interest in the role of steatosis-induced liver injury. Excess TG accumulation activates a number of cellular stress signaling and inflammatory pathways, such as c-Jun N terminal kinase (JNK) and nuclear factor B (NF B), that may eventually lead to apoptosis, giving rise to the phenomenon termed "lipotoxicity" (6, 7) .
NASH is associated with a significant decrease in plasma adiponectin levels which correlates with the severity of liver histology (8) . The metabolic effects of adiponectin are mediated by two putative receptors: adiponectin receptor R1 (AdipoR1) and adiponectin receptor R2 (AdipoR2). The former is primarily expressed in muscle, while the latter is expressed in liver (9) . At the cellular/molecular level, AdipoR2 mRNA expression is decreased in most (10-13) but not all (14, 15) liver samples from NASH patients as compared to control patients, with no difference in AdipoR1 mRNA expression (10) . Yamauchi et al. have shown that adenovirus-mediated over-expression of either AdipoR1 or AdipoR2 in liver reversed steatosis-linked insulin resistance in diabetes (16) . This was recently confirmed by Tomita et al. in a methionine-deficient and choline-deficient mouse model of NASH (17) . Conversely, the repair process of liver injury (18, 19) . Thus, this raises the possibility that the loss of hepatic AdipoR2 receptor in NASH patients may play an important role in worsening many of the metabolic, enzymatic, and gene regulatory changes that characterize human NASH patients (8, 20) . However, very little information is currently available about the interaction between steatosis and loss of adiponectin receptor expression in hepatic cells.
Emerging evidence suggests that the ability to counter-regulate inflammatory responses plays an important role in metabolic control through regulation of endoplasmic reticulum (ER) stress (21, 22) .
Metabolic disorders including obesity and alcohol ingestion can cause protein misfolding or overloading in the ER, triggering a stress cascade with pathological consequences including inflammation and cell death (23, 24) . When mammalian cells are subjected to protein overload in the ER, an immediate response is activation of the pancreatic eukaryotic translation initiation factor alpha kinase (PERK) to inhibit protein biosynthesis through phosphorylation of eukaryotic translation initiation factor alpha (eIF2 ) (21) .
If the overload of unfolded or misfolded proteins in the ER is not resolved, prolonged activation leads to programmed cell death requiring increased CCAAT/enhancer binding protein (C/EBP) homologous protein (CHOP/GADD153), a transcription factor that potentiates apoptosis (25) . The transcription factor C/EBP is also activated in the liver through the actions of cytokines, hormones, nutrients, and ER stress (26, 27) and has been suggested to play an important role in pro-inflammatory and apoptotic pathways (28).
The main aim of the present study was to investigate the effects of lipid loading and the therapeutic effects of the PPAR agonist fenofibrate on expression of AdipoR2 and levels of phosphorylated AMPK (pAMPK) in Huh7 human hepatoma cells and in the Huh.8 cell line which stably expresses a hepatitis C virus (HCV) subgenome replicon (29). These cells display many features of HCVinduced fatty liver disease; including increased intracellular lipid accumulation and activation of JNK by a reactive oxygen species-ER stress pathway (30, 31). Fenofibrate is widely used as a hypolipidemic drug that activates PPAR , and thereby regulates the expression of a number of genes critical for lipid and lipoprotein metabolism (32-34), leading to lipid catabolism in the liver and reduction in total body fat as by guest, on August 15, 2017 www.jlr.org Downloaded from well as circulating plasma lipids (35). We also investigated whether ER stress played a causal role in the loss of AdipoR2 and pAMPK in response to lipid overload. We found that ER stress inducers thapsigargin (TPG) and tunicamycin (TUN) caused a loss of AdipoR2 and pAMPK in Huh7 cells, while treatment with the chemical chaperone 4-phenylbutyrate (PBA), an agent used to reduce ER stress, restored palmitate-and TPG-mediated reduction of AdipoR2 expression and AMPK phosphorylation in both the parental Huh7 cell line and in Huh.8 derived cells. Our results demonstrate that ER stress is associated with decreased AdipoR2 and pAMPK levels and suggest that fenofibrate and PBA might be important therapeutic agents to prevent metabolic abnormalities by reducing ER stress associated with fatty liver disease.
MATERIALS AND METHODS

Cell culture and treatment
The cell lines used in this study, Huh7 and Huh.8, were provided by Dr. Charles Rice (Rockefeller University, New York, NY). The Huh.8 cell line was derived from the parental Huh7 cells and contains an HCV-derived expression vector stably integrated into the Huh7 background. The expression vector includes the HCV proteins NS2, NS3, NS4A, NS4B, NS5A, and NS5B linked to the antibiotic selection marker G418 (29). The Huh7 parental cell lines were cultured in DMEM containing high glucose (25 mM) supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate, and 10% fetal bovine serum (all from Sigma-Aldrich, St Louis, MO). Huh.8 cells were maintained in complete DMEM (25 mM glucose) supplemented with 10% heat-inactivated fetal bovine serum, nonessential amino acids, and 1 mg/ml G418 (Gemini Bio-Products, West Sacramento, CA). Cells were maintained at 37°C for 2-3 passages in a humidified environment containing 5% CO 2 . For experimental treatments, Huh7 and Huh.8 cells were serum-starved overnight and treated with different concentrations of palmitate, fenofibrate (Sigma), TUN (Sigma), or PBA (Calbiochem) as indicated in the appropriate figure legends. 
Palmitate preparation
The conjugation of palmitate and albumin was prepared in order to deliver a final concentration of 200 M palmitate in the tissue culture medium. One mol of palmitic acid was conjugated to three mols of albumin (both from Sigma). A 200 mM palmitic acid solution was prepared by dissolving 0.256 g palmitic acid in 5 ml of 100% ethanol and separately, a 27% (W/V) albumin solution was prepared in PBS. From there the conjugate (palmitate:albumin) was prepared by adding 4.5 ml of 27% albumin to 250 l of 200 mM palmitate solution. The final volume was brought to 5 ml with PBS after adjusting to pH7.4. The 10 mM palmitate stock was added directly to the culture without further dilution. The appropriate controls for experiments using palmitate contained 0.1% ethanol and 0.5% albumin.
Preparation of cytosolic, membrane, and nuclear fractions
Cytosolic and nuclear extracts were prepared as previously reported (28). For analysis of AdipoR2 protein levels, membrane fractions were prepared by centrifuging the cytosolic extract in a Beckman ultracentrifuge at 60,000 rpm for 2 h. The pellets were resuspended in 50 l of hypotonic buffer (10 mM HEPES, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride (PMSF), 2 g/ml each of aprotinin and leupeptin, and 0.5 mg/ml benzamidine). For phospho-protein assays, cells were prepared and quantitated as described previously (28).
Immunoblot analysis
Lysates were subjected to SDS-PAGE and Western blot analysis as previously described (28).
Primary antibodies used in this study were C/EBP , CHOP, PPAR , actin, and GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA), pJNK, pAMPK (Thr172), AMPK, phospho-eIF2 , and eIF2 (Cell 
Extraction of lipid and measurement of TG content
Lipids were extracted from cells using the procedure of Bligh and Dyer (36). Quantitative enzymatic measurements of TG content were performed in triplicate using TG determination reagents (Sigma).
RESULTS
Fenofibrate treatment prevented palmitate-induced loss of AMPK phosphorylation and AdipoR2 expression in Huh7 cells
We checked the effects of palmitate and palmitate in combination with fenofibrate on pAMPK and AdipoR2 levels in Huh7 human hepatoma cells. Huh7 cells were grown in complete DMEM (25 mM glucose) treated with either 200 M palmitate alone or in combination with two concentrations of fenofibrate (50 and 100 M), a known hypolipidemic agent. Palmitate significantly suppressed both pAMPK and AdipoR2 levels and co-incubation with fenofibrate prevented palmitate-induced suppression of pAMPK and AdipoR2 expression in Huh7 cells (Fig. 1, A and B) . In addition, we found that fenofibrate treatment alone (100 M) for 24 h increased pAMPK levels and AdipoR2 protein expression in Huh7 cells (Fig. 1, C and D) .
Fenofibrate reduced palmitate-mediated induction of ER stress and inflammatory proteins
The ER stress response has recently been recognized in the pathogenesis of liver disease, including apoptosis, fat accumulation, and inflammation (37). To determine whether the positive effects of fenofibrate had any effect on reducing ER stress in palmitate-treated Huh7 cells, we monitored the expression of C/EBP and phospho-eIF2 , two key proteins induced by two different arms of the ER stress pathway (38, 39). Palmitate treatment (200 M) significantly increased phospho-eIF2 levels while co-incubation with fenofibrate (100 M) markedly reduced phospho-eIF2 expression ( showed a six-fold increase in TG concentration, while fenofibrate alone or co-incubation with palmitate significantly lowered TG levels compared to levels in control or palmitate-treated Huh7 cells (respectively, Fig. 2D ). These results demonstrate that fenofibrate treatment prevented TG accumulation, reduced pJNK activation, and reduced phospho-eIF2 and C/EBP protein levels, suggesting the ability to lower ER stress levels.
TPG increased the expression of C/EBP and CHOP proteins while fenofibrate restored TPG-and TUN-mediated reduction of AMPK phosphorylation and AdipoR2 expression in Huh7 cells
Having established an effect of fenofibrate on lowering markers of ER stress and restoration of AdipoR2, we then went on to ask whether treatment with two ER stress-inducing agents, TPG and TUN, might be causative for reduced AdipoR2 and pAMPK levels in Huh7 cells, and to test the efficacy of fenofibrate. Huh7 cells treated with 1 M TPG increased C/EBP and CHOP protein levels ( suggesting a reduction in ER stress. However, PBA did not reduce palmitate-mediate induction of TG levels in Huh7 cells (Fig. 4F) . This result provides evidence that ER stress, rather than lowering TG, might contribute to reduced AMPK phosphorylation and AdipoR2 expression and that suppression of ER stress can restore AMPK phosphorylation and AdipoR2 expression.
Fenofibrate treatment restored AMPK phosphorylation and AdipoR2 expression and reduced pJNK activation in HCV-induced Huh.8 cells
Hepatitis C is well known to induce insulin resistance and steatosis (43, 44) and is associated with loss of AdipoR2 mRNA expression in human liver in vivo (11) . Furthermore, it is well recognized that HCV invades the ER and induces ER stress with profound effects on normal ER functions (45). In the Huh7-derived cell line Huh.8 engineered with HCV, AdipoR2 expression was significantly lower compared to Huh7 cells (Fig. 5A) . Interestingly, AdipoR2 levels were further reduced by addition of TPG in Huh.8 cells (Fig. 5A) investigate the effects on pAMPK and AdipoR2 levels. Addition of fenofibrate, especially at concentrations of 75 and 100 M, increased (50-800%) both pAMPK and AdipoR2 expression (Fig. 5, B and C), while fenofibrate at 100 M for 24 h significantly reduced C/EBP and pJNK activation (Fig. 6,   A and B) . Huh.8 cells contain a two-fold increase in levels of TG storage in the absence of palmitate treatment compared to the parental Huh7 cell line (Fig. 2D vs. Fig. 6C ). However fenofibrate treatment (50 and 100 M for 24 h) failed to reduce TG accumulation in Huh.8 cells (Fig. 6C) . These results indicate that fenofibrate-mediated augmentation of AdipoR2 levels in Huh.8 cells is independent of TG content.
DISCUSSION
These present studies suggests that exposure to saturated fatty acids may contribute to ER stressrelated down regulation of AdipoR2 and loss of pAMPK in the liver in addition to hepatic steatosis. Our results suggest that ER stress is an important pathological feature associated with down-regulation of AdipoR2 and pAMPK levels in human hepatoma cells exposed to fatty acids. In Huh7 cells, palmitate significantly reduced AdipoR2 protein levels, while treatment with fenofibrate blocked fatty acidmediated loss of AdipoR2 levels and reduced levels of ER stress indicators phospho-eIF2 and pJNK. We also show the chemical inducers of ER stress TPG and TUN reduced pAMPK and AdipoR2 levels. To further demonstrate that reversing ER stress had the opposite effect we treated Huh7 cells with PBA, an agent that clears misfolded proteins from the ER and lowers ER stress in cells and animals (46). PBA prevented both palmitate-and TPG-induced loss of AdipoR2 and pAMPK levels in Huh7 cells (Fig. 4) , suggesting that relieving ER stress with either PBA or fenofibrate can restore AdipoR2 and pAMPK.
We also observed a restoration in AdipoR2 and pAMPK levels in HCV-infected Huh.8 cells treated with fenofibrate despite no change in TG content, indicating that fenofibrate-mediated increase in AdipoR2 levels in Huh.8 cells is independent of TG content. These results imply a different mechanism(s) other than simply reducing TG could be involved in the effect of fenofibrate to restore levels of AdipoR2 and pAMPK. Huh.8 cells have defects in several pathways of fatty acid metabolism (oxidation, export, de-novo lipogenesis, and uptake (47-49)) that may cause TG levels to be unchanged with fenofibrate. Although the mechanism for the fenofibrate effect on restoring AdipoR2 and ER stress without changing TG levels in Huh.8 cells is unclear, it is possible that such mechanisms as reducing the impairment in protein folding or membrane trafficking may be important contributors to the restoration of AdipoR2. However, more studies are necessary for clarification.
While ER stress activity is acutely induced by fatty acids, this process is adaptive; in Huh.8 cells exposed to the ER stress agent TPG there was a further loss of AdipoR2 (Fig. 5A) . These results suggest that other virally-induced events in addition to ER dysfunction may play an important role in the downregulation of AdipoR2 expression in hepatitis C. ER stress also has been reported to induce reactive oxygen species production (46). It has been shown that PBA reduces inducible nitric oxide synthase and tumor necrosis factor alpha (TNF ) expression (50) Although the mechanism underlying ER stress-induced loss of AdipoR2 protein and pAMPK remains to be elucidated, these results suggest that fenofibrate and PBA might be useful therapeutic agents to correct lipid-and stress-mediated metabolic abnormalities. and membrane fractions (for AdipoR2) were prepared as described in Materials and Methods. Values are means ± SE of two independent experiments run with three replicates and expressed as % change over control (setting control to 100) after normalization to AMPK for pAMPK and actin for AdipoR2.
Statistical significance was estimated using a nonpaired Student's t test. *P < 0.05 vs. control, **P < 0.05
vs. palmitate-treated cells. Values are means ± SE of two independent experiments run with three replicates and expressed as % change over control (setting control to 100) after normalization to GAPDH for C/EBP and CHOP, AMPK for pAMPK, and actin for AdipoR2. Statistical significance was estimated using a nonpaired Student's t test. *P < 0.05 vs. control, **P < 0.05 vs. TPG-or TUN-treated cells. palmitate-treated cells. with three replicates and expressed as % change over control (setting control to 100) after normalization to AMPK for pAMPK and actin for AdipoR2. Statistical significance was estimated using a nonpaired Student's t test. *P < 0.05 vs. control. 
